Envoy Medical COCH Cash Flow Statement (2020-2026)

NASDAQ COCH
$6.74 -0.07 (-1.03%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Envoy Medical Quarterly Cash Flow Statement

Periods 24 quarters
Latest Sep 2026

Envoy Medical reported cash from operations of -$5.03M and free cash flow of -$5.06M for the quarter ended Sep 2026, down 16.1% year over year. This cash flow statement covers 24 quarters of results from Dec 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-4.72M-1.87M-1.24M-1.34M-11.48M-13.25M-13.34M1.56M-4.90M-6.27M-3.95M-5.96M-4.62M-5.00M-5.69M-6.48M-6.59M-4.35M-5.98M-3.93M
Depreciation and DepletionDep. & Depletion
0.03M0.03M0.03M0.03M0.05M0.03M0.04M0.05M0.05M0.06M0.09M0.08M0.08M0.07M0.07M0.08M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
-1.13M0.19M-0.01M0.01M0.23M0.27M0.26M0.38M0.50M0.62M0.47M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.03M0.03M0.03M0.05M0.03M0.04M0.05M0.05M0.06M0.09M0.08M0.08M0.07M0.07M0.08M
Share-based CompensationStock Comp.
0.12M0.14M0.14M0.15M0.16M0.15M0.17M0.18M0.24M0.21M0.31M
Gains from Investment SecuritiesGains Investment
0.04M0.56M3.37M0.53M0.74M
Other non-cash itemsOther Non-Cash
4.15M-14.21M-3.47M-1.33M-0.05M-0.01M0.27M-0.09M0.55M0.51M-0.24M0.31M-0.53M-0.21M-0.04M-0.06M0.14M0.17M-0.02M-0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.06M-0.03M0.04M0.05M0.11M-0.14M0.25M0.02M-0.16M0.00M0.00M-0.01M0.00M0.00M0.02M0.00M
Change in InventoryChange Inventory
-0.03M0.11M-0.09M0.14M0.30M-0.20M0.14M-0.07M-0.04M0.11M-0.13M-0.04M0.10M-0.09M
Change in Account PayablesChange Payables
-0.18M0.04M0.23M-0.51M0.58M1.02M0.34M1.02M-1.83M-0.64M0.68M0.17M-0.22M0.01M-0.04M1.01M0.41M-1.22M0.31M-0.43M
Change in Accrued ExpensesChange Accrued Exp.
0.09M0.58M-0.47M-0.21M0.24M-0.18M0.32M0.56M-0.79M-0.36M-0.98M1.30M-0.21M0.20M0.11M-0.10M0.62M0.66M-0.91M0.26M
Change in TaxesChange Taxes
-0.26M0.24M-0.53M1.71M
Change in Other Operating AssetsOther Assets Change
-0.03M0.09M-0.17M0.11M-0.08M0.04M0.13M0.70M-0.02M0.06M-0.22M-0.53M1.29M-0.68M-0.04M0.03M-0.07M0.12M-0.16M0.15M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.49M-0.08M0.01M3.97M-4.03M-0.03M0.76M-0.89M0.91M-0.02M-0.02M0.05M-1.11M-0.05M-0.10M-0.05M
Other Working Capital ChangesOther WC Changes
0.03M-0.09M0.17M-0.11M-0.42M-0.12M-0.12M3.27M-4.01M-0.08M0.98M-0.36M-0.39M0.66M0.01M0.01M-1.04M-0.17M0.06M-0.20M
Cash from OperationsCash from Ops.
-0.89M-0.77M-0.40M-5.25M-2.38M-3.01M-4.03M1.10M-11.15M-5.59M-4.65M-2.62M-5.09M-3.73M-4.46M-4.33M-5.69M-6.06M-5.46M-5.03M
Investing Activities
Capital ExpendituresCapex
0.04M0.06M0.01M0.06M0.02M0.11M0.79M0.62M-0.53M0.01M0.00M0.17M0.03M
Change in Property, Plant and EquipmentChange in PP&E
-0.04M-0.06M-0.01M-0.06M-0.02M-0.11M-0.79M-0.62M0.53M-0.01M0.00M-0.17M-0.03M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
1.44M0.25M
Other Investing Activities (as filed)Other investing (as filed)
-0.11M-0.43M
Cash from Investing ActivitiesCash from Investing
-0.04M-0.06M-0.01M-0.06M-0.02M-0.11M-0.79M-0.62M0.53M-0.01M0.00M-0.17M-0.03M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.75M0.75M4.50M2.00M4.00M3.00M3.00M5.00M2.50M7.50M5.00M5.00M5.00M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.75M0.75M4.50M2.00M4.00M3.00M3.00M5.00M2.50M7.50M5.00M5.00M5.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.75M0.75M4.50M2.00M4.00M3.00M3.00M5.00M2.50M7.50M5.00M5.00M5.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M1.68M0.43M1.44M0.69M-0.41M2.87M-0.04M30.00M0.10M
Shares Repurchased
387.61M2.00
Net Shares Issued and RepurchasedNet Shares Issued
-387.61M-2.000.01M1.68M0.43M1.44M0.69M-0.41M2.87M-0.04M30.00M0.10M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
0.83M1.95M1.04M15.71M
Net Equity Issued and RepurchasedNet Equity Issued
0.83M-385.65M1.04M15.71M1.68M0.43M1.44M0.69M-0.41M2.87M-0.04M30.00M0.10M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
1.32M1.37M1.37M-0.45M0.80M0.03M0.65M1.27M1.15M1.35M1.29M1.31M
Dividends Paid - Common and PreferredDiv Paid (Total)
1.32M1.37M1.37M-0.45M0.80M1.21M0.65M1.27M1.15M1.35M1.29M1.31M
Other financing activities (as filed)
0.00M4.03M-0.26M-0.26M-0.18M-0.21M-0.23M-0.24M-0.17M-0.25M-0.21M-0.21M-0.15M
Cash from Financing ActivitiesCash from Financing
0.00M0.75M0.75M4.59M2.00M4.00M3.00M15.74M-1.45M6.43M2.24M5.92M5.62M3.55M4.44M2.60M6.04M27.57M-0.11M-0.05M
Additional items
Exchange Rate EffectFX Effect
-0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M0.00M0.00M0.00M
Change in Cash
-0.88M-0.02M0.35M-0.84M-0.43M0.93M-1.05M16.77M-12.62M0.73M-3.20M2.68M1.06M-0.17M-0.03M-1.73M0.18M21.51M-5.57M-5.11M
Beginning Cash Balance
Ending Cash Balance
1.12M0.13M0.48M0.61M0.18M1.11M0.07M16.84M4.22M4.95M1.75M4.22M5.48M5.48M5.48M5.48M5.48M3.74M3.74M3.74M
Free Cash FlowFCF
-0.89M-0.77M-0.40M-5.25M-2.42M-3.07M-4.05M1.04M-11.17M-5.70M-5.44M-3.24M-4.56M-3.73M-4.46M-4.33M-5.86M-6.06M-5.46M-5.06M
Net Cash FlowNCF
-0.88M-0.02M0.35M-0.66M-0.42M0.93M-1.05M16.77M-12.62M0.73M-3.20M2.68M1.06M-0.18M-0.02M-1.73M0.18M21.51M-5.57M-5.11M
Interest Paid
0.01M0.01M0.00M0.02M0.01M0.01M0.00M0.01M0.01M0.01M0.00M
Income Taxes PaidTaxes Paid
1.38M0.32M

Envoy Medical Cash Flow Statement API

Pull Envoy Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=COCH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY